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ABSTRACT 
Losses of skeletal calcium and body fluids occur during prolonged exposure to 
microgravity. The kidney plays a major role in regulating the physiological functions 
involved. Relative to this regulatory function, the kidney performs three operations: 
filtration of blood plasma through the glomeruli, reabsorption, and secretion of fluid and 
electrolytes so that needed components are retained and only waste is eliminated in the 
urine. 
Using data published in "Biomedical Results from Skylab" (l), we performed new 
calculations that reflect more directly the operations of the kidney in the handling of 
calcium, sodium, chloride, potassium and phosphate during space flight. These 
calculations revealed that the fraction of filtered calcium that was rejected by renal 
flight) of the filtered load. This represents a large absolute increase because the total 
filtered amount is huge. Because the tubular rejection fraction of other ions increased 
relatively less than that of calcium, we postulate the inflight development of a specific 
renal defect that causes an excessive loss of calcium in urine and thereby contributes to 
the weakening of bones. 
I tubules and excreted in the urine increased by 71%, from 1.77% (preflight) to 3.02% (in- 
Because the reabsorption of glomerular filtrate (the conservation of body fluids and 
electrolytes by the kidney) depends upon the energy of adenosinetriphosphate (ATP) and 
enzymes that liberate its energy, we propose that an induction of the major renal enzyme 
system involved, sodium and potassium-dependent adenosinetriphosphatase, may improve 
the reabsorption of sodium directly and calcium indirectly and thereby lead to improved 
hydration and reduced calcium loss. 
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INTRODUCTION 
Because of the known detrimental shifts of fluids and electrolytes, particularly 
calcium losses, that occur under conditions of microgravity, we undertook an evaluation 
of renal function studies during the Skylab flights and of renal handling of important 
ions. Using data published in "Biomedical Results from Skylab" (l), we performed new 
calculations that reflect more directly the operations of the kidneys of astronauts under 
conditions of microgravity. 
To make this report clear to the nonspecialist, we now give a brief summary of 
pertinent renal physiology, in part derived from Pitts (2). The two kidneys weigh about 
300 grams and thus constitute 0.4% of total body weight. In humans, each kidney is 
composed of about one million units called nephrons, which function in parallel. Each 
nephron begins with a glomerulus (microscopic sieve) attached to a tubule. Fluid filtered 
by the glomeruli passes through the renal tubules, to collecting ducts and eventually to 
the urinary bladder. The kidneys receive the greatest blood flow, in proportion to 
weight, of any organ of the body. Renal blood flow is equal to 20-25% of cardiac output 
or about 2000 liters per day. Urine formation starts with the filtration of blood plasma 
. through the glomeruli at the rate of about 200 liters per day. The renal tubules 
reabsorb needed components of the glomerular filtrate, which contain most constituents 
of blood plasma excluding protein, and add to the filtrate undesirable products by 
secretion. The net result is excretion of waste in urine at an average rate of two liters 
per day. Thus, about 99% of glomerular filtrate is reabsorbed. Given the fact that an 
average adult has 40 liters of fluid in the body, the internal autodialysis of all body 
fluids through the kidneys takes place five times every 24 hours (200 liters of glomerular 
filtrate/40=5). The net result of renal filtration, reabsorption and secretion is the 
regulation of composition, within narrow limits compatible with life, of body fluids, often 
referred to as the constant internal environment. 
METHODS 
Glomerular filtration rates (GFR) and renal handling of ions were estimated (2,3) 
based on plasma and urinary concentrations obtained from published data from the nine 
crewmen who participated in Skylab flights (Tables 1 and 2). Where appropriate, plasma 
concentrations of substances obtained at different times were averaged to match the 
periods of urinary excretion data available. 
The renal clearance of a substance is defined as the number of milliliters of plasma 
cdmpletely cleared of that substance in one minute. If the substance is completely 
filterable through glomeruli, that is, it is neither reabsorbed nor secreted, if it has no 
effect on renal function, and if it can be accurately measured in plasma and urine, then 
its clearance can be taken as a valid measure of GFR. Normal GFR per 1.73 square 
meters of body surface area, standard for an adult, averages 125 ml/min in men and 110 
ml/min in women. In healthy persons, GFR is remarkably stable from day to day over a 
period of years. 
The formula for calculation of renal clearance is U x V/P, where U and P represent 
concentrations of the substance in urine and plasma (mg/ml) respectively, and V 
represents urine formation rate in ml/min. If the clearance of a given substance is 
larger than the simultaneous GFR, that substance is said to be "secreted" by the tubules 
of the kidney. If clearance of a substance is smaller than GFR, the substance is said to 
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be "reabsorbed." It should be noted that, in the absence of more detailed studies, the 
clearance of a substance is a net figure and does not take into account simultaneous 
secretion and reabsorption that might also be taking place. 
The standard method of determination of GFR is by measurement of inulin clearance 
following intravenous infusion. Inulin is a high (5,000) molecular weight polysaccharide 
that is completely filterable and is neither secreted nor absorbed by the kidney. 
Obviously, this method cannot be used during space flight. Instead, measurement of 
endogenous creatinine clearance, which agrees reasonably well with the inulin clearance, 
is usually taken as an approximate measure of GFR and was used in our calculations. 
Creatinine is a product of muscle creatine phosphate; its production is constant and is 
proportional to muscle mass. Renal elimination of creatinine is also constant. The 
! 
I agreement of GFR as measured by inulin and by creatinine clearances results from the ~ 
I balance of two errors: 1) the analysis method slightly overestimates the creatinine 
concentration in plasma (but not in urine), and this gives the appearance of a lower 
creatinine clearance; and 2) the true clearance of creatinine is slightly higher than GFR 
because of tubular secretion. These are the limitations in using creatinine clearance as 
an approximate measure of GFR in these studies. 
Filtration rate of an ion (mg/min) through glomeruli was calculated by multiplying its 
filterable concentration in plasma (mg/ml) by the GFR (ml/min). Because 40% of plasma 
calcium is bound to plasma proteins, which are too large to pass through the glomeruli, 
the filterable fraction of calcium was taken as 60% of total plasma calcium. Phosphate 
was assumed 90% filterable. Virtually all plasma sodium, potassium and chloride are 
freely filterable. 
I The tubular reabsorption rate (mg/min) of an ion is its filtration rate (mg/min) minus 
its excretion rate (mg/min). Tubular rejection fraction or fractional excretion (%) was 
calculated .by the formula: Excretion rate (mg/min)/ filtration rate (mg/min) x 100. This 
yields the percentage of the filtered quantity of a given ion that escaped tubular 
I reabsorption. 
RESULTS 
Renal function data calculated from Tables 1 and 2 are shown in Table 3. Creatinine 
clearances proved remarkably stable throughout the missions, indicating intact renal 
vascular autoregulatory mechanisms that control the GFR in the face of the well known 
circulatory disturbances and body fluid shifts that occur during space flight (4-6). In 
flight, GFR's held within 2-3% of the preflight values and fell only a modest 9% during 
the 60-85 day flight period. 
I Tubular reabsorption of individual ions was depressed during flight and reverted 
postflight to baseline, preflight values (Fig. 1). Peak fractional excretion rose 71% (from 
1.77% to 3.02%) for calcium, 12% for phosphate, 38% for chloride and 40% for sodium. 
This indicates a generalized increased tubular rejection of several ionic components of 
the glomerular filtrate with a relative selectivity for calcium. 
The data for renal handling of calcium are plotted in Figure 2. The curves for 
fractional excretion and urinary excretion rate of calcium were similar: the former 
exhibited a smoother natural progression, suggesting that this was the mechanism for 
I increased calcium loss in the urine. Increased fractional excretion coincided with a 
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slight but significant rise in plasma calcium concentration (peak 6%). Filtered and 
reabsorbed calcium increased (peak 8-9%) during flight and paralleled the creatinine 
clearance curve throughout. Thus, the increased fractional excretion of calcium during 
flight was the dominant finding. 
To see more clearly the mechanism of tubular transport of calcium, in Figure 3 we 
have plotted renal calcium handling adjusted per 100 ml of GFR. The curve for the 
urinary calcium excretion rate resembled more closely the curve for fractional calcium 
excretion than that shown in Figure 2. The adjusted filtration and reabsorption rates of 
calcium remained parallel but became more stable than those shown in Figure 2, and peak 
increases during flight were only 4-5%. This is further evidence that the calcium 
excreted in urine appears there as a result of diminished tubular reabsorption. 
The urinary excretion of 0.29 gm of calcium per day during the Skylab flights was 
Thus, 7.8 to 11.05 gm of calcium 
These amounts are equal 
nearly twice that of control values of 0.16 gm per day. 
were lost during 59 day and 84 day Skylab flights respectively. 
to more than the total of extraskeletal intracellular and extracellular calcium stores. 
DISCUSSION 
The outstanding finding of our study is that renal tubular reabsorption of calcium 
abruptly diminished during space flight and rapidly returned to control levels after 
landing. This resulted in urinary excretion of 0.29 gm of calcium per day during flight, 
up from 0.16 gm per day control rate. The net total calcium loss attributable to the 
kidney during the Skylab flights of 59 to 84 days equaled 7.8 gm to 11.05 gm 
respectively. The crewmen had an adequate average dietary intake of 0.73 gm calcium 
per day but went into negative calcium balance because fecal calcium excretion also 
increased (1,7). The calcium-wasting by the kidney is further demonstrated by the lack 
of renal conservation of calcium in the face of the increased fecal calcium losses. 
To place the magnitude of the calcium loss in perspective, it is essential to realize 
that all extracellular body fluids contain only about 1 gm of calcium, cells contain 5 gm, 
and bone contains a total of 1,200 gm (3). Thus, any sizeable calcium loss, like that 
which occurred during the Skylab flights, must come eventually from bone. Calcium 
homeostasis involves continuous mineral turnover in bone, absorption from food and 
reabsorption by the kidney. Overall calcium metabolism is primarily set to maintain a 
constant calcium concentration in extracellular fluid, even at the expense of bone 
density. Absorption from the gut is controlled by vitamin D, bone resorption and renal 
reabsorption are promoted by parathyroid hormone and inhibited by calcitonin (3,8). 
Based on the above considerations, options for prevention of calcium loss are: 1) 
increase intake and/or decrease losses of calcium from the gut; 2) decrease calcium loss 
from bone; and 3) decrease calcium loss from the kidney. Relative to option 1, stable 
and adequate calcium intake during Skylab flights did not prevent negative calcium 
balance (1,7). In fact, there was an increased amount of calcium lost in feces (7). 
Enhancement of calcium absorption from food deserves further study. 
Decreased egress of calcium from bone appears to be under most intensive 
investigation at present as a solution to bone demineralization during space flight. In 
our opinion, producing a halt to bone resorption without increased absorption from the 
gut and reduced loss via the kidneys would lead to a reduced intracellular and 
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I extracellular calcium concentration. Since calcium is required for muscular contraction 
and nerve conduction, inadequate calcium levels may lead to increased weakness and 
atrophy, already a problem during space flight (9). Diminished supply of calcium to the 
heart could lead to impairment of cardiac output and to irregularities of heart rhythm 
(arrhythmias) that could result in sudden death. 
I 
i 
Relative to the third option, reversal of the acquired defect in tubular reabsorption 
of calcium would be a desirable solution to the excessive calcium loss during space flight. 
Because renal calcium reabsorption is in part dependent upon the transport of sodium, we 
propose that an induction of renal sodium and potassium-dependent 
adenosinetriphosphatase (Na and K ATPase), an enzyme system that allows the use of 
adenosine triphosphate (ATP) for ion transport (lo), would improve tubular reabsorption 
of sodium directly and that of calcium secondarily. In addition to calcium conservation, 
this maneuver would improve reabsorption of sodium, chloride and water, all of which are 
also excessively lost during space flight. Methods for induction of renal Na and K 
ATPase deserve further investigation in an attempt to prevent osteoporosis and fluid and 
electrolyte loss associated with space travel. The magnitude of renal-related calcium 
losses, coupled with the fact that Skylab astronauts had adequate calcium intake and 
excessive fecal calcium losses, make it wise to consider ways in which renal losses of i calcium can be curtailed. 
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TABLE 23-V.-Skylab Summary, Plasma Biochemical Results (9 Crewmen) 
(Mean f Standard error) 
No. Sdum' Pobssium Ch&ride Creatinine Clueosc OsmolaLity Ccrlcium Phosphate 
nwq/litcr m e q / l i t u  meq/liter mg pet. m g  pct. mOsmolcs mg pet. mg pet. 
36 PreAight 141 f 0.7 4.12 f 0.04 97.7 f 0.5 126 f 0.03 86.6 f 0.03 290 f 0.8 9.7 f 0.05 3.4 f 0.1 
9 
8 
6 
6 
6 
6 
6 
6 
3 
3 
Mission 
3, 4 
5, 6 
13, 14 
20, 21 
27, 30 
38 
45, 48 
58, 59 
73 
82 
&U 
139 f 2 4.26 f 0.08 96.8 f 0.7 1.31 f 0.03 
'137 * 2 4.30 f 0.14 96.9 f: 0.8 1.27 f 0.03 
137 f 1 4.41 f 0.15 '94.7 f 1.1 1.28 f 0.03 
140 f 1 4.25 f 0.11 95.7 f 0.8 1.35 f 0.03 
'138 f 0.8 4.25 f 0.10 '95.2 f 0.8 1.27 t 0.03 
'136 f 2 '4.05 f 0.15 93.5 t 1.2 1.31 f 0.07 
'137 f 2 4.30 f 0.13 94.5 f 0.7 1.34 f 0.03 
'137 f 2 4.19 2 0.13 94.0 t 1.5 1.38 f 0.12 
137 f 0.6 4.19 f 0.06 95.8 2 0.2 1.54 f 0.03 
139 f 2 3.75 f 0.20 94.6 f 1.2 1.51 f 0.05 
90.3 f 2.4 
86.7 f 1.8 
86.7 f 1.8 
87.0 f 1.8 
84.3 f 2.3 
'80.1 f 2.5 
'84.4 f 1.4 
'81.8 f 2.2 
80.9 f 2.2 
'81.0 f 1.2 
289 2 1 
'287 f 1 
286 f 2 
289 f 2 
'287 t: 2 
'280 f 4 
287 f 3 
2 8 6 2 4  
284 f 2 
'285 f 2 
'10.4 f 0.1 
' 10.2 f 0.1 
10.2 f 0.1 
' 10.1 f 0.2 
10.4 f 0.1 
10.1 f 0.2 
3.7 f 0.3 
3.6 f 0.3 
3.9 f 0.3 
' 3.4 f 0.1 
* 3.9 f 0.3 
'3.1 f 0.5 
10.1 f 0.1 
10.1 f 0.2 
10.1 f 0.3 
10.1 f 0.1 
3.8 f 0.1 
3.8 t 0.2 
*3.9 t 0.2 
3.6 f 0.1 
Recoveru (R) 
9 R + O  139 f 1 4.18 2 0.05 *96.2 2 1.0 1.28 f 0.05 '100.5 f 2.6 289 f 1 '10.0 f 0.1 '3.9 f 0.2 
9 R + l  139 f 1 4.10 f 0.08 '96.4 f 1.0 1.31 0.06 92.3 f 2.8 289 f 1 '10.1 f 0.1 '3.6 f 0.03 
3.4 f 0.2 9 R + 3 , 4  139 f 1 4.02 f 0.13 96.9 f 1.0 1.26 2 0.06 '90.5 f 1.4 '294 f 2 
6 R + l 4  141 2 0.8 4.06 f 0.05 97.7 f 1.6 1.33 f 0.09 86.4 f 0.7 289 f 2 '9.4 f 0.1 2.8 f 0.2 
9.8 f 0.1 
- 
' - 'Cor& for Na-EDTA. * p l O . O S .  
TABLE 23-VI .4ky lab  Summary, Plasma Biochemical Resdts (9 Crewmen) 
(Mean f Standard error) 
No. CWtbol An&temkl Aldorkrone ACTH I d i n  HCH PTH 
39 Preflight 122 f 0.7 0.77 f 0.14 180225 3blfc43.8 1 7 2 0 . 6  d = 0 2  ?fL? rg/lW ml ng/ml p~ hour pg/100 ml @ U / d  n /ml 
9 
8 
6 
6 
6 
6 
6 
6 
3 
3 
Mission Day 
3, 4 
5, 6 
13, 14 
20, 21 
27, 30 
38 
45, 48 
58, 59 
73 
82 
12.7 f 1.6 
'11.8 f 1.0 
13.4 f 1.7 
12.3 f 1.6 
13.6 f 21 
13.7 f 1.0 
14.3 f 1.3 
13.5 f 0.7 
14.5 f 3.4 
' 16.1 f 0.6 
1.09 f 0.24 
1.75 f 0.42 
.91 f 028 
.52 f 0.12 
.45 f 0.16 
.72 f 0.36 
3 7  f 0.10 
' 1.11 f 0.51 
.27 f 0.08 
.32 f 0.04 
1 7 6 2  58 '15.2 f 4.9 15 f 2 'El f 0.5 
163 f 75 26.5 f 9.2 18 IS 6 1.2 f 0.3 
1.6 f 0.2 252 f 65 33.02 8 18 f 3 
1.2 f 0.3 1 6 3 f 9 0  '11.9f 4 ' 8 a l  
2 0 4 2 8 8  32.0 f 7 20 f 3 3.2 f 2.0 
94 f 17 17.7 f 11.6 '10 f 1 1.1 = 0.3 
118 f 7 l 1 2 1 f  5.8 ' 9 2 2  1.5 f 0.5 
148 f 31 32.3 f 18.7 9 2 2 1.6 f 0.4 
117 f 39 9 2 4  0.6 f 0.1 
142 f 17 11 f 4 0.7 f, 0.1 
17 f 2 
16 f 3 
14 f 1 
20 f 4 
14 f 2 
15 f 2 
18'2 4 
18 2 3 
24 . f  2 
2 5 2 2  
Recovecy (R)  
23.8 f 6.3 20 f 3 2.9 f 0.6 17 f 2 9 R+O 13.2 f 2.1 .71 f 0.23 215 f 74 
'2.8 f O . 8  1 9 2 3  9 R + l  10.8 f 1.0 l2.15 f 0.65 l478 f 77 l24.0 f 7.5 20 f 2 
9 R + 3 , 4  13.7 = 3.0 .86 f 0.45 '357 f 66 23.3 f 2.4 18 f 2 l2.6 f 0.8 19 f 3 
9 R +  13, 14 10.6 2 0.7 '.14 f 0.05 153 f 35 38.2 f 13.9 17 f 3 1.220.2 1 8 + 4  
0.OR 
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Figure 1 .  Renal function of nine Skylab crewmen: Fractional 
excretion of calcium, phosphate, sodium, and chloride. The data 
indicate f i l tered fractions of these ions that escaped reabsorp- 
tion and were excreted in  urine. 
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Figure 2. 
o f  calcium i n  nine Skylab crewmen. 
i n  the figure are relat ive to preflight values. 
Plasma calcium concentration, GFR, and renal handling 
Peak percent changes indicated 
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Figure 3. 
Skylab crewmen. 
relative to preflight values. 
Renal handling of calcium per 100 ml/min GFR in nine 
Peak percent changes indicated in the figure are 
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